Lundbeck has made available Sabril (vigabatrin) powder for oral solution and tablets for the treatment of infantile spasms and refractory complex partial seizures. Sabril oral solution is indicated as monotherapy for infantile spasms in children 1 month to 2 years of age. Sabril tablets are indicated for adults in combination with other treatments for refractory complex partial seizures that have not responded adequately to previous drug therapies. Sabril is associated with a risk of progressive loss of peripheral vision with potential decrease in visual acuity, and thus is only indicated when the benefits of treatment outweigh the potential risk of vision loss. Because of the risk of permanent vision damage, Sabril will be available only through the restricted distribution program SHARE (Support Help and Resources for Epilepsy).
Sabril is available as 500mg packets of powder for oral solution and as 500mg dosage strength tablets.
For more information call (888) 457-4273 or visit www.sabril.net.